Christiane E. Angermann

Always striving for a better life for patients with heart failure.

[Christiane E. Angermann @CEAngermann]

@BettinaHeideck1 Pleasure to share this experience! Let's use win statistics prospectively @dzhi_di90 and @ChariteBerlin together to further explore healthcare research in #heartfailure!

[Christiane E. Angermann @CEAngermann]

@ChristophMaack Great hospitality and exciting discussion about new joint research projects @mountsinai and @DZHI_Wuerzburg to unravel the secrets of SGLT2 inhibotor effects on #heart iron metabolism in #heartailure! Thank you so much, and come to visit us soon!

[Carlos G Santos-Gallego, MD @SantosGallegoMD]

@ChristophMaack We missed you, @ChristophMaack!

[Christiane E. Angermann @CEAngermann]

@PKleinbongard @TRassafMD Congratulations! Great work, a MUST read!

[EMBO @EMBO]

Anne Ephrussi wins the @FEBSnews | EMBO Women in Science Award 2024. Congratulations! Today, on International Day of Women and Girls in Science, we recognize her achievements with this award.
https://t.co/6Zsw1WAITv
#WomenInScience #IDWGIS #11Feb
@embl

[Christiane E. Angermann @CEAngermann]

@jordivangestel much luck!!!

[Jordi van Gestel @jordivangestel]

Fantastic meeting! Please apply!

[Christiane E. Angermann @CEAngermann]

@jordivangestel This sounds, as if even clinicians like me would gain a lot from attending!

[Christiane E. Angermann @CEAngermann]

Universitätsklinikum Würzburg: Multimorbidität bei Herzinsuffizienz https://t.co/BoBDSk53B6

[Christoph Maack @ChristophMaack]

Improvement of LV function by empagliflozin correlates with myocardial iron uptake in HFrEF- intriguing work @NatureCVR by @CEAngermann @DZHI_Wuerzburg collaborating w/@SantosGallegoMD &Juan Badimon➡️https://t.co/tPyXsYEnVJ @NatRevCardiol @AG21_DGK @dzhk_germany @ArdehaliHossei

[Deutsche Gesellschaft für Kardiologie @DGK_org]

#LateBreakingClinicalTrials: Prof. Christiane E. Angermann (@CEAngermann ) präsentierte die Ergebnisse der EMPULSE trial Studie auf der #DGKJahrestagung.

[Harriette Van Spall, MD MPH 🇨🇦 @hvanspall]

@JTThibs @JACCJournals @EiranGorodeski @docbhardwaj @bhtrachtenberg @adrianjdasilva @ersied727 @KevinShahMD @Nikhil15 @md_viviana @Abraham_Jacob @MHBeasleyMD Great to see the long term results of this trial from C Angermann & team published @JACCJournals. Below is an open access link to the editorial with a brief thread.

[Jenny Thibodeau, MD, MSCS @JTThibs]

New @JACCJournals #JACCHF 18mos of remote patient monitoring ➡️ delayed benefit in all-cause hospitalization, all-cause death, CV death, CV hospitalization. Why might that be?

👀https://t.co/nGGMEBqiJO

[Christiane E. Angermann @CEAngermann]

Share with us exciting new perspectives on opportnities in every day management of our patients with heart failure!

[Radcliffe Cardiology @radcliffeCARDIO]

✅ Earn 1 CME credit with this discussion, which provides a reflection on the HF landscape following published data at congress! https://t.co/4K1tyjZGjT

@CEAngermann @FaiezZANNAD @NMHheartdoc @JavedButler1

Not intended for US or UK HCPs.
#Cardiology #Cardiologists #CPD #MedEd

[Christiane E. Angermann @CEAngermann]

Great read for all who want to take a deep dive in HFpEF pathophysioloy!

[Christiane E. Angermann @CEAngermann]

Congratulations to Louisa Gerhardt for demonstrating that while prevalence and severity of CKD and anaemia rise along the HF trajectory, population attributable fractions of mortality risk are ~30% across all the ACC/AHA stages. Read more at https://t.co/Or4ft2vBK6

[Christiane E. Angermann @CEAngermann]

@ChristophMaack Great translational work! Congratulations!

[Christiane E. Angermann @CEAngermann]

@ChristophMaack @DZHI_Wuerzburg @dzhk_germany @DGK_org @escardio @AHAScience So glad about this success of DZHI! Well done and well deserved!

[Christiane E. Angermann @CEAngermann]

@ChristophMaack @DZHI_Wuerzburg @SantosGallegoMD @AHAMeetings @DGK_org @escardio Let's dig even deeper and clarify this exciting finding further at the bench!

[Christoph Maack @ChristophMaack]

Reverse card. remodelling in pat. with #heartfailure in resp. to SGLT2 inh. correlates w/ ⬆️ myocardial iron content, possibly triggered by ⬇️hepcidin levels, as presented by @CEAngermann @DZHI_Wuerzburg collabor. w/@SantosGallegoMD et al. @AHAMeetings #AHA21 @DGK_org @escardio